Patient Newsletter – May 2023

May 2023

Inside this edition, we will be covering the following topics:

  • Legs Out Roundup

  • 2023 Budget Announcements 

  • Chemo Brain

  • Chronic Disease GP Management Plan

  • Spotlight on a clinical trial

  • Medication approvals

  • Missed our recent Relapsed Refractory webinar – watch it here or listen on Spotify

  • Upcoming events – young adult series, Hodgkin Lymphoma, Supporting Families, CLL Hybrid event

  • Support groups upcoming dates

  • Nurse Support Line 1800 953 081 
Image showing symptoms of chemo brain including Changes in concentration or attention span, memory changes, confusion, difficulty multi-tasking, difficulty learning new skills, difficulty finding words, foggy or sluggish

Click here to read the May 2023 Patient Newsletter

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.